Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Lorena Oróstica"'
Autor:
Lorena Lobos-González, Lorena Oróstica, Natalia Díaz-Valdivia, Victoria Rojas-Celis, America Campos, Eduardo Duran-Jara, Nicole Farfán, Lisette Leyton, Andrew F. G. Quest
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 23, p 16947 (2023)
Caveolin-1 (CAV1) is a membrane-bound protein that suppresses tumor development yet also promotes metastasis. E-cadherin is important in CAV1-dependent tumor suppression and prevents CAV1-enhanced lung metastasis. Here, we used murine B16F10 and huma
Externí odkaz:
https://doaj.org/article/8cfcddb850ce4b739e93958ecd7a1548
Autor:
Maritza P. Garrido, Ignacio Torres, Alba Avila, Jonás Chnaiderman, Manuel Valenzuela-Valderrama, José Aramburo, Lorena Oróstica, Eduardo Durán-Jara, Lorena Lobos-Gonzalez, Carmen Romero
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 20, p 7657 (2020)
Nerve Growth Factor (NGF) and its high-affinity receptor tropomyosin receptor kinase A (TRKA) increase their expression during the progression of epithelial ovarian cancer (EOC), promoting cell proliferation and angiogenesis through several oncogenic
Externí odkaz:
https://doaj.org/article/4947c31d9dec4b11b37eb7ea92e29cf3
Autor:
Rocío Retamales-Ortega, Lorena Oróstica, Carolina Vera, Paula Cuevas, Andrea Hernández, Iván Hurtado, Margarita Vega, Carmen Romero
Publikováno v:
International Journal of Molecular Sciences, Vol 18, Iss 3, p 507 (2017)
Ovarian cancer is the eighth most common cancer in women worldwide, and epithelial ovarian cancer (EOC) represents 90% of cases. Nerve growth factor (NGF) and its high affinity receptor tyrosine kinase A receptor (TRKA) have been associated with the
Externí odkaz:
https://doaj.org/article/e2e5272cdaee41ee9e666f87cedcd3a5
Autor:
Maria Lorena Oróstica, Isis Astorga, Francisca Plaza-Parrochia, Cristian Poblete, Rodrigo Carvajal, Víctor García, Carmen Romero, Margarita Vega
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 7, p 3922 (2022)
Polycystic ovary syndrome (PCOS) is an endocrine/metabolic disorder associated with insulin resistance (IR) and obesity. Endometria from women with PCOS present failures in insulin action, glucose uptake and signaling of insulin-sensitizing molecules
Externí odkaz:
https://doaj.org/article/c98865319f5149bb94cca3e516f207cb
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Integrative Cancer Science and Therapeutics. 8
Autor:
Francisca Plaza-Parrochia, Margarita Vega, Lorena Oróstica, Carmen Romero, Ignacio Torres-Pinto, Heidy Cabrera-Cruz
Publikováno v:
American journal of physiology. Endocrinology and metabolism. 318(2)
Polycystic ovary syndrome (PCOS) is an endocrine-metabolic disorder characterized by hyperandrogenism and ovulatory dysfunction but also obesity and hyperinsulinemia. These characteristics induce an insulin-resistant state in tissues such as the endo
Publikováno v:
Translational Cancer Research. 6:S1371-S1383
Autor:
Carmen Romero, Fernando Gabler, Margarita Vega, Carolina Vera, Lorena Oróstica, Alberto Selman, Arturo Ferreira
Publikováno v:
International Journal of Oncology. 50:1261-1270
Ovarian cancer is the seventh most common cancer among women worldwide, causing approximately 120,000 deaths every year. Immunotherapy, designed to boost the body's natural defenses against cancer, appears to be a promising option against ovarian can
Publikováno v:
Reproductive sciences (Thousand Oaks, Calif.). 27(1)
A pro-inflammatory environment is characteristic of obesity and polycystic ovary syndrome (PCOS). This environment through cytokines secretion negatively affects insulin action. Endometria from women with both conditions (obesity and PCOS) present hi